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regional parts, especially in LV basal region. NYHA classiﬁcation, pro-BNP
and basal septal ENDO LS were independent predictors of AL-CA.
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OBJECTIVES Cardiac amyloidosis (CA), an inﬁltrative restrictive cardio-
myopathy, is usually delayed in diagnosis, leading to poor prognosis. The
aim of the study is to evaluate characteristics and prognosis of CA to
enable early diagnosis and optimal management for cardiologists.
METHODS We retrospectively analyzed 53 patients (63.2% men, mean
age 60.39.8 years) with biopsy-proven diagnosis of systemic
immunoglobulin light chain amyloidosis (AL) in our institution from
January 1993 to December 2014. Clinical features, outcomes and
possible prognostic factors on survival were evaluated.
RESULTS A total of 32 (60.4%) patients were diagnosed as CA with a
median diagnostic duration of 8 months. Only 12 (37.5%) of CA patients
referred to Cardiology Department before diagnosis including 11 (91.7%)
with congestive heart failure (CHF) and 1 (8.3%) with advanced atrio-
ventricular block. Nineteen (59.4%) CA patients presented with more than
3 organs involved. The cardiovascular symptoms of CA include dyspnea
on exertion (46.9%), lower limbs edema (71.9%), nocturnal paroxysmal
(18.8%), hypotension (28.1%), chest pain (6.3%), syncope (15.6%) and
cardiac arrest (6.3%). Electrocardiographic manifestations include poor R
wave progression (84.6%), low QRS voltage (46.7%), pseudo-infarct
pattern (46.7%) and conduction disturbances (28.3%). The mean thickness
of interventricular septum on echocardiography was 1.50.3 cm. CA pa-
tients with CHF had lower systolic blood pressure (102.314.5 vs.
124.621.9 mmHg, P¼0.004) compared with those without CHF. During a
median follow up of 20 months, CA group showed tendency of poor
prognosis compared with Non-CA group (median survival time: 27 vs. 40.5
months, P¼0.124). Hypotension was signiﬁcantly associated with poor
prognosis in both systemic AL amyloidosis and CA patients (HR 5.312,
P¼0.010; HR 4.523, P¼0.020, respectively).
CONCLUSIONS CA is not rare in systemic AL amyloidosis and frequently
underrecognized. The prognosis was poor with hypotension being the
negative predictors of survival. For patients with newly-onset hypoten-
sion, accompanied with other manifestations like increased wall thickness
and low QRS voltage, CA should be considered.
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OBJECTIVES Dilated cardiomyopathy (DCM) is a myocardial disease with
a high mortality rate. Approximately 40 genes have been found to be
associated with DCM to date. Non-familial DCM can also be caused by
gene mutations, suggesting that genetic factors were involved in the
pathogenesis of DCM; therefore genetic testing is beneﬁcial for the early
diagnosis of DCM, which can facilitate the implementation of preventive
measures by and within patient families. Here we investigated the un-
derlying genetic mutations involved in the cause of patients with DCM.
METHODS This prospective study included 240 patients with idiopathic
DCM and 240 healthy volunteers. Subject clinical data were collected and
polymerase chain reaction ampliﬁcation was carried out on subject DNA for
three candidate genes tropomyosin (TPM1), troponin T (TNNT2), and lamin
A/C (LMNA). Single nucleotide polymorphism (SNP) loci were detected in
the TPM1 (rs1071646) and TNNT2 (rs3729547) genes respectively.
RESULTS The genotype distributions and allele frequencies were found
to satisfy Hardy-Weinberg equilibrium, which indicated that the group
was representative. Statistically signiﬁcant differences were found be-
tween the variant frequencies in the two SNP loci between the Kazakh
patients with IDCM and healthy volunteers. A signiﬁcant difference in the
genotype distributions (P ¼0.000) and allele frequencies (P ¼0.000) of
SNP rs1071646, and another signiﬁcant difference in the genotype dis-
tributions (P ¼0.000) and allele frequencies (P ¼0.039) of SNP rs3729547
between Kazaks with IDCM and Kazak controls.CONCLUSIONS These results suggests that the TPM1 (rs1071646) and
TNNT2 (rs3729547) gene variant might represent risk factors for pa-
tients with DCM in the Kazakh population.
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OBJECTIVES Recent studies have shown that gender and age are
associated with outcomes in patients with cardiomyopathy. The
purpose of this study was to determine the all-cause mortality of
dilated cardiomyopathy (DCM) by age and gender.
METHODS An observational cohort study of DCM patients was conducted
from November 2003 to September 2011. During this time, 1142 patients
were enrolled, with a mean follow-up period of 3.62.3 years. De-
mographic information, transthoracic echocardiography data, and routine
blood test results were obtained for each patient shortly after admission.
All-cause mortality after admission was the primary outcome assessed.
RESULTS The patients were divided into non-elderly (age <60 years,
n ¼811) and elderly (age 60 years, n ¼331) groups, and no difference
in the all-cause mortality rate was observed between the elderly and
non-elderly patients (27.2% vs. 22.2%, log-rank c2 ¼2.604, P ¼0.107).
Furthermore, no signiﬁcant difference in mortality was observed be-
tween the male and female patients (23.3% vs. 24.5%, log-rank
c2 ¼0.707, P ¼0.400). However, a subgroup analysis revealed that the
elderly male patients exhibited a higher mortality rate than that of the
non-elderly male patients (29.4% vs. 21.3%, log-rank c2 ¼5.898,
P ¼0.015), while no difference was observed between the elderly fe-
male patients and the non-elderly female patients. In the Cox anal-
ysis, neither age nor gender was a signiﬁcant independent predictor of
all-cause mortality in patients with DCM.
CONCLUSIONS In conclusion, no signiﬁcant difference in mortality
between male and female patients or between the elderly and non-
elderly patients was observed. Only among males was a difference in
mortality observed; elderly male patients experienced greater mor-
tality than that of non-elderly male patients. No effect of age or
gender on all-cause mortality was observed in patients with DCM.
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OBJECTIVES To observe the clinical features and cardiac magnetic
resonance imaging characteristics of patients with cardiac
amyloidosis(CA).
METHODS Totally 79 patients with CA admitted to First Afﬁliated Hos-
pital of Sun Yet-sen University from 2005 to 2014 were included. CA was
conﬁrmed by endocardium biopsy examination or had the manifestations
of the cardiac magnetic resonance imaging characteristics when the pa-
tients did not have endocardium biopsy but had renal, tongue, or
alimentary canal biopsy only. Clinical manifestations and cardiac mag-
netic resonance imaging were collected for the evaluation.
RESULTS 54 cases(68.4%) with heart failure, 39 cases(49.4%) with
chest pain,60 cases(75.9%) presented with dyspnea, 20 cases (25.3%)
presented with diarrhea, 26 cases (32.9%) presented with hypertrophy
of tongue, and 57cases(72.2%) with renal insufﬁciency and protein-
uria. Echocardiogram showed all of the CA patients had concentric left
ventricular hypertrophy, granular appearance of the myocardium, left
atrial enlargement and 56 cases (70.8%) had moderate to severe left
ventricular diastolic dysfunction. Cardiac magnetic resonance imag-
ing revealed 75 cases (94.9%) increased thickness of the left ventric-
ular wall, 70 cases (88.6%) had enlarged bilateral auricle, and 56
cases(70.8%) had restricted left ventricular ﬁlling with normal or mild
to moderate reduced systolic function.
CONCLUSIONS For patients who were with unexplained clinical car-
diac failure, chest pain, renal insufﬁciency and echocardiogram
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myocardium should be considered in the diagnosis of CA. Cardiac
magnetic resonance imaging is valuable in the diagnosis of CA.
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OBJECTIVES Arrhythmogenic right ventricular dysplasia/cardiomyopa-
thy (ARVD/C) is an inherited cardiac disease associated with an increased
risk of arrhythmic sudden death. Mutations in desmosomal genes and
some extra-desmosomal genes have been identiﬁed to associate with
ARVD/C. Previously we identiﬁed 5 novel plakophilin (PKP2) mutations in
a cohort of Chinese patients with ARVD/C. Our present study is to deter-
mine the prevalence of other associated gene mutations in this ARVD/C
registry study and explore the potential genotype- phenotype relationship.
METHODS Genotypic and phenotypic proﬁles were studied in a cohort
of 32 symptomatic Han Chinese with a clinical or suspected diagnosis
of ARVD/C according to modiﬁed international Task Force criteria in
2010. Direct sequencing of 5 desmosomal genes and 3 extra-desmo-
somal genes was performed with a 3730XL DNA Analyzer.
RESULTS 22 mutations including 13 novel (13/22, 59.1%) in 5 desmo-
somal genes PKP2, Desmoplakin (DSP), Desmoglein-2 (DSG2), Des-
mocollin-2 (DSC2), Plakoglobin (JUP) were identiﬁed in 20 (20 of 32,
55.6%) patients in our cohort. No mutations were found in extra-
desmosomal genes. Among 32 patients, 11 (11 of 32, 34.4%) patients
have PKP2 mutations, 3 (9.4%) DSP, 3 (9.4%) DSG2, 6 (18.8%) DSC2
and 4 (12.5%) JUP. Multiple mutations were found in 6 subjects (6 of
32, 18.8%), among which 4 have PKP2 mutation, 3 DSC2, 3 DSP and 3
JUP. Genotype-phenotype analysis indicates compound multiple
mutations may predict major structural abnormalities.
CONCLUSIONS PKP2 mutation is the most common gene mutations
in our ARVD/C cohort. A higher percentage of DSC2 and JUP mutations
were identiﬁed in the cohort compared with previous reports. Com-
pound multiple mutations are common and may indicate major
structural abnormalities. Extra-desmosomal genes mutations are rare
in our Chinese ARVD/C cohort.
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OBJECTIVES Contrast echocardiography with left ventricular opaci-
ﬁcation (LVO) can improve endocardium deﬁnition and potentially
becomes supplement of conventional two-dimensional echo (2DE) in
the diagnosis of noncompaction of the ventricular myocardium
(NCVM). This study aimed to access the feasibility, accuracy, repro-
ducibility of LVO & its incremental value than 2DE in NCVM diagnosis.
METHODS LVO & 2DE were performed in 85 patients (54 men, mean
age 4020 years) with suspected NCVM (NCVM Gp), and 2DE were
performed in 40 healthy volunteers (Normal Gp, 20 men, mean age 40
 23 years). The LV chamber size and LV ejection fraction derived
from Biplane Simpson’s formula were compared among LVO-NCVM
Gp, 2DE-NCVM Group & 2DE-Normal Gp. The location and extent of
NCVM were evaluated based on AHA/ACA 16 segment model for LV
segmentation, and the thickness ratio of noncompacted to compacted
myocardium (NCR) were assessed on LVO & 2DE by 2 independently
blinded experienced echo-cardiologists.
RESULTS (1) Compared with the Normal Gp, the NCVM Gp showed
larger LVEDD (58.911.6mm vs. 455.1mm), LVEDV (12111.5ml vs.
9514.8), LVESD (43.03.44mm vs. 334.0mm), LVESV (74.33.94ml
vs. 444.4ml), lower LVEF (40.813.2% vs. 65.67.1%) and E/A ratio
(0.820.32 vs. 1.620.5) using 2DE method (p<0.05).
(2) Within the NCVM Gp, compared with the values from 2DE
method, LVEDD (65.27.8mm vs. 58.911.6mm), LVEDV (16214.8mlvs. 12111.5ml), LVESD (47.85.67mm vs. 43.03.44mm), LVESV
(84.72.46ml vs. 74.33.94ml) derived from LVO method were larger
and LVEF (38.212.4 vs. 40.813.2) on LVO was slightly lower (p<0.05).
(3) Among the whole 1360 LV segments in NCVM Gp, there were
more segments adequately visualized for analysis on LVO than on 2DE
(1278 vs. 1183, 93.97% vs. 86.99%). There were more noncompaction
segments detected on LVO than on 2DE (314 vs. 262, 23.09% vs.
19.26%). Of the 921 segments interpreted as normal on 2DE, 52 seg-
ments (5.65%) were noncompacted on LVO. NCVM on LVO were
majorly located in medium (53.18%), apical (46.18%) segments and
lateral wall (39.81%); rarely involved in basal segment (0.64%).
(4) NCR on LVO was greater than that on 2DE (4.21.3 vs. 3.31.2,
P<0.0001), but they are highly related and both showed excellent
interobserver consistency. The coefﬁcient of inter-observer variability
of NCR was slightly smaller using LVO than 2DE (5.2% vs. 6.6%).
(5) The NCVM detection rate using 2DE, LVO, 2DEþLVO were sta-
tistically different, with the highest detection rate on 2DEþLVO and
lowest detection rate on 2DE (89.4% vs. 63.5%, p<0.05).
CONCLUSIONS Contrast echo can clinically improve the diagnosis of
NCVM in accuracy, sensitivity & reproducibility, and act as a useful
supplement to the routine two-dimensional transthoracic echo.
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OBJECTIVES Hypertrophic cardiomyopathy (HCM) is the most com-
mon genetic cardiovascular disorder.This genetic diversity modiﬁer
genes form the basis of its phenotypic heterogeneity.
METHODS Clinical, three-dimensional speckle tracking (3D-STI),
electrocardiographic (ECG), cardiac magnetic resonance (CMR) and
echocardiographic(UCG) examination in members of a three-genera-
tion Chinese family was followed by exon and boarding intron anal-
ysis of 96 genes in the proband using second-generation sequencing.
The identiﬁed mutations were conﬁrmed by bi-directional Sanger
sequencing in all family members and 300 healthy controls.
RESULTS The deleted mutation 3624 del C in exon 31 of the MYBPC3
gene were identiﬁed in proband and two family members(subjects I-2,
III-1).While the remaining family and 300 normal controls did not ﬁnd
this mutation. The onset ageproband is 42 years old and subject I-2 is
50 years old. Both of them were accompanied by chest pain. Subject
III-1 UCG and CMR were normal. However his ECG showed sinus
bradycardia and paroxysmal supraventriculararrhythmias. CMR re-
sults showed that proband has myocardial ﬁbrosis in base-septal and
anterior wall of left ventricular. Subjects I-2 has myocardial ﬁbrosis in
middle-septal, anterior wall and inferior wall of left ventricular.
Themutation carriers showed septal, anterior wall, inferior wall and
apical of left ventricular hypertrophy in UCG compared with the no-
mutation carriers, in the family; In 3D-STI, the global and the
segmental longitudinal strain in middleof the posterior interventric-
ular septum, the base and the middle of anterior interventricular
septum, and the middle of the left ventricular anterior wall were
reduced. Furthmore the segmental area strain in the base of the
anteriorinterventricular septum were reduced (P <0.05).
CONCLUSIONS We demonstrate a close correlation between clinical
phenotype and genotype of MYBPC3 gene Pro1208fs mutation in a
Chinese family with HCM for the ﬁrst time. The mutation results in
100% penetrance. Mutation carriers arelate age of onset and no spe-
ciﬁc clinical symptoms. Partial myocardial ﬁbrosis and Maron III type
hypertrophy and a high potential of abnormal myocaidial systolic
function were detected suggesting the pathogenesis of themutation.
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OBJECTIVES Dilated cardiomyopathy (DCM) is characterized by left
ventricular enlargement, systolic dysfunction, and heart failure. Both ge-
netic and non-genetic factors have been linked to DCM pathogenesis.
Familial DCM (FDCM) accounts for 20%-50% of all DCM cases, highlighting
the importance of genetic in pathogenesis. Indeed, more than 40 DCM
